- €477.56m
- €569.86m
- €318.98m
- 55
- 53
- 46
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 300 | 297 | 286 | 314 | 319 |
Cost of Revenue | |||||
Gross Profit | 240 | 248 | 239 | 263 | 267 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 286 | 280 | 268 | 360 | 271 |
Operating Profit | 14.3 | 17.6 | 17.3 | -46.4 | 47.6 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 12.2 | 13.6 | 16.5 | -47.4 | 42.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.41 | 8.48 | 9.6 | -40 | 35.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5.41 | 8.47 | 9.6 | -40 | 35.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.41 | 8.48 | 9.6 | -40 | 35.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.264 | 0.405 | 0.436 | -1.56 | 2 |
Dividends per Share |